CARDIFF ONCOLOGY INC
CRDFNASDAQ🏆 #3818 by market capEarnings Oct 29US Equity
$1.03▼ $0.02 (−2.38%)
Live1h▼ 1.4%
24h▼ 2.4%
7d▲ 7.7%
14d▲ 25.9%
30d▼ 24.4%
1y▼ 58.0%
🏦Market Cap
$79M
Small Cap
📈Revenue Growth (YoY)
-13.2%
Declining
📊Gross Margin
100.0%
High
💵FCF Margin
-10127.7%
Thin
⚖️P/S Ratio
200.3x
Expensive
Otter Score
56
Weak
📊
Analyst Ratings
Price
$1.03
Total
14
Raised
1
Lowered
6
Avg PT
$2.00
H / L
$2 / $2
| Institution | Action | Rating | Date |
|---|---|---|---|
Craig-Hallum | Downgraded | Buy → Hold | 2026-06-03 |
TD Cowen | Downgraded | Buy → Hold | 2026-06-01 |
HC Wainwright & Co. | Downgraded | Buy → Neutral | 2026-06-01 |
Piper Sandler | Reiterated | Overweight | 2026-02-25 |
Baird | Reiterated | Outperform | 2022-08-29 |
Maxim Group | Reiterated | Buy | 2020-09-18 |
Noble Financial | Reiterated | Outperform | 2019-03-08 |
PiperJaffray | Downgraded | Neutral → Underweight | 2017-03-16 |
Cantor Fitzgerald | Upgraded | Hold → Buy | 2016-08-08 |
Leerink Swann | Downgraded | Outperform → Perform | 2016-04-26 |
Avondale Partners | Reiterated | Market Perform → Perform | 2016-03-29 |
Janney Capital | Downgraded | Buy → Neutral | 2016-03-11 |
Aegis Capital | Reiterated | Buy | 2013-11-15 |
Roth Capital | Reiterated | Buy | 2012-12-20 |
One row per institution, most recent rating